Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-24 @ 4:08 PM
NCT ID:
NCT06742866
Eligibility Criteria:
Inclusion Criteria:
* Participants aged ≥18 years;
* First-time catheter ablation for persistent atrial fibrillation (defined as any - previous episode lasting ≥7 days);
* Symptomatic atrial fibrillation patients who have failed or are intolerant to at least one class I or III antiarrhythmic drug;
* Participants who are able to understand the purpose of the study, voluntarily agree to participate, and provide written informed consent.
Exclusion Criteria:
* Those unwilling or unsuitable to restart or continue antiarrhythmic drug therapy;
* Life expectancy \< 12 months;
* Severe liver or kidney dysfunction;
* Allergy to amiodarone components;
* Pregnant or breastfeeding women;
* Contraindications to amiodarone (e.g., blood pressure \< 90/60 mmHg; bradycardia \< 55 bpm, second- or third-degree AV block, or sick sinus syndrome);
* Thyroid disorders, such as hyperthyroidism or hypothyroidism.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06742866
Study Brief:
Protocol Section:
NCT06742866